Company news

Silexion Therapeutics Corp news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Silexion Therapeutics to Present SIL-204 Data in KRAS-Driven Pancreatic Cancer at the 2025 ASCO Gastrointestinal Cancers Symposium

January 12, 2025

Silexion Therapeutics collaborates with Evonik on advanced siRNA Formulation Development

December 16, 2024

Silexion Therapeutics Appoints Renowned Cancer Therapeutics Expert Prof. Amnon Peled to Board of Directors

December 9, 2024

Silexion Therapeutics Announces 1-for-9 Reverse Share Split

November 21, 2024

Silexion Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

November 13, 2024

Silexion Therapeutics Reports Breakthroughs From SIL-204 Preclinical Studies

September 30, 2024

Silexion Therapeutics Announces Significant New Data from Phase 2 Trial of LODER™ in Non-Resectable Pancreatic Cancer

September 23, 2024

← Newer news releases

Decks

The 5 newest of 8 decks. Every deck is listed under its year.